Open AccessComparative study of hemodynamic responses during laryngoscopy and endotracheal intubation with dexmedetomidine and esmolol
Author(s) -
Vigneshwaran Chandramohan,
Ramya Natarajan,
Vishwanath R. Hiremath
Publication year - 2022
Publication title -
asian journal of medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2091-0576
DOI - 10.3126/ajms.v13i3.40791
Subject(s) - medicine , dexmedetomidine , esmolol , anesthesia , laryngoscopy , intubation , propofol , hemodynamics , saline , rocuronium , blood pressure , heart rate , sedation
Background: Many drugs used to reduce the hemodynamic stress response during laryngoscopy and endotracheal intubation. The quest for ideal drugs and their dosage without major side effects is still pursued. Dexmedetomidine, an alpha-2 agonist, is emerging as a promising drug to counteract the catecholamine release.Aims and Objectives: This study is done to compare the effect of lower doses dexmedetomidine and esmolol in control of hemodynamic response and stability in cases undergoing laryngoscopy and endotracheal intubation during general anesthesia.Setting and Design: This was a prospective, randomized double-blinded comparative study.Materials and Methods: After approved by the Institute Ethics Committee, consent obtained from 60 patients (n=60) belonging to ASA I or II. Patients were equally divided into twogroups (D and E). Group D patients (n=30) were infused with intravenous dexmedetomidine at 0.75 mcg/kg diluted in 20 ml with normal saline 10 min before induction. Group E patients (n=30) were infused with intravenous esmolol 0.75 mg/kg diluted in 20 ml of normal saline 2 min before intubation. After administration of drugs, SBP, DBP, MAP, HR, and SpO2 were recorded, immediately after induction, after intubation at 1 min, 3 min, 5 min, and 10 min, respectively.Results: Data wereentered into Microsoft Excel datasheet and wereanalyzed using SPSS 22 version software. In the study, there was a significant decrease in SBP, DBP, MAP, and HR from administration till 10 min after intubation inGroup D compared to Group E. No severe hypotension or bradycardia was seen in any of the patients in either group, took part in our study.Conclusion: This study concludes low dose of dexmedetomidine (0.75mcg/kg) was superior to low dose of esmolol (0.75 mg/kg) in maintaining of hemodynamic stability in response to laryngoscopy and tracheal intubation without any significant adverse effects even though both drugs were comparable in suppressing pressor response.